New York, NY – December 10, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today a publication in Clinical and Translational Science, titled: “Syndication in Science:...
Read More
NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that Regeneron has become a member of its Data Syndication Program for the LEARNS observational study. This...
Read More
New York, NY – March 20, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced that Merck, known as MSD outside of the United States and Canada,...
Read More
